59° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Community Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viridian Therapeutics, Inc. - Common Stock (NQ:VRDN)

18.09 +0.40 (+2.26%)

Streaming Delayed Price Updated: 9:46 AM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viridian Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 30, 2022

Via Benzinga

Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket ↗

November 30, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) shares rose 33.3% to $0.2399 in pre-market trading after jumping 45% on Tuesday. Kalera recently announced restructuring process for German...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 30, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Wednesday!

Via InvestorPlace

Viridian's Thyroid Eye Disease Candidate Shows Encouraging Early Data, Shares Surge ↗

August 15, 2022

Via Benzinga

Recap: Viridian Therapeutics Q2 Earnings ↗

August 15, 2022

Viridian Therapeutics (NASDAQ:VRDN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 29, 2022

Via Benzinga

At Higher Dose, Viridian's Thyroid Eye Disease Candidate Shows Significant, Rapid Improvement In Signs & Symptoms ↗

November 14, 2022

Via Benzinga

Viridian Therapeutics Earnings Perspective: Return On Capital Employed ↗

September 09, 2022

Benzinga Pro data, Viridian Therapeutics (NASDAQ:VRDN) reported Q2 sales of $256 thousand. Earnings fell to a loss of $29.49 million, resulting in a 14.78% decrease from last quarter.

Via Benzinga

Why Viridian's CEO Isn't Sweating His Company's Second-Place Position ↗

August 31, 2022

The company didn't plan to be first in thyroid eye disease. But it hopes to be best.

Via Investor's Business Daily

$10 Million Bet On This Casino Stock? 4 Stocks Insiders Are Buying ↗

August 22, 2022

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 15, 2022

Via Benzinga

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Via Benzinga

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday ↗

August 16, 2022

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

Via Benzinga

Viridian Therapeutics (VRDN) Stock Jumps 60% on Promising Clinical Trial ↗

August 15, 2022

Viridian Therapeutics is among the biggest winners on Monday as it released encouraging clinical data, thus skyrocketing VRDN stock.

Via InvestorPlace

Gold Drops Over 1%; Viridian Therapeutics Shares Spike Higher ↗

August 15, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 15, 2022

Via Benzinga

Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On Monday ↗

August 15, 2022

Magic Empire Global Limited (NASDAQ: MEGL) shares climbed 80.9% to $14.87 on volatility following the company's IPO earlier this month.

Via Benzinga

Dow Surges Over 100 Points; Crude Oil Falls Sharply ↗

August 15, 2022

U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.

Via Benzinga

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session ↗

August 15, 2022

Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...

Via Benzinga

New Contender Viridian Takes Aim At Horizon's Eye Drug, And Rockets ↗

August 15, 2022

Horizon has the only approved thyroid eye disease treatment in the U.S., for now.

Via Investor's Business Daily

Viridian Therapeutics (NASDAQ: VRDN) Shares Positive Clinical Data from Phase 1/2 Trial of VRDN-001 for Treatment of Thyroid Eye Disease

August 15, 2022

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is engaged as a biotechnology company, which is focused on the research and development of

Via Spotlight Growth

U.S. Stocks Edge Lower; NY Empire State Manufacturing Index Drops In August ↗

August 15, 2022

U.S. stocks traded slightly lower this morning, with the Dow Jones dropping around 40 points on Monday.

Via Benzinga

Why Viridian Therapeutics Stock Is Soaring Today ↗

August 15, 2022

Viridian Therapeutics Inc (NASDAQ: VRDN) shares are trading higher Monday after the company reported better-than-expected top-line results and announced initial clinical data from its ongoing trial of...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 15, 2022

Via Benzinga

Earnings Scheduled For August 15, 2022 ↗

August 15, 2022

Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022 ↗

June 23, 2022

Upgrades

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Viridian Therapeutics, Inc. with Losses to Contact the Firm

June 16, 2022

From The Schall Law Firm

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 13, 2022

Via Benzinga

110 Biggest Movers From Friday ↗

May 16, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Via Benzinga

56 Stocks Moving In Friday's Mid-Day Session ↗

May 13, 2022

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Viridian Therapeutics, Inc. - Common Stock (NQ:VRDN)

All News about Viridian Therapeutics, Inc. - Common Stock

Sections

Services